Clinical trial
Identification of Biomarker Profiles for Individualized Prognostic Stratification and Therapy in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia (GEP-NEN)
NCT02838862 is registered in ClinicalTrials.gov with University Hospital Schleswig-Holstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Biomarker Profiles for Individualized Prognostic Stratification and Therapy in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia (GEP-NEN)
- Lead sponsor
- University Hospital Schleswig-Holstein
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2016
- Completion date
- June 30, 2017
- Enrollment
- 470 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.